Ongoing Clinical Trials in Intracerebral Hemorrhage
نویسندگان
چکیده
منابع مشابه
Ongoing clinical trials in intracerebral hemorrhage.
ntracerebral hemorrhage (ICH) accounts for 10% to 15% of all strokes. ICH continues to impart a considerable degree of morbidity and mortality, with 30-day mortality ranging from 44% to 50%. ICH remains a devastating disease, and current treatment options lag far behind those for ischemic stroke. There are no approved therapies, which improve outcome, and treatment remains mainly supportive. De...
متن کاملClinical grading scales in spontaneous intracerebral hemorrhage.
Clinical Grading Scales in Spontaneous Intracerebral Hemorrhage To the Editor: We have had the pleasure to read the article by Dr RuizSandoval and colleagues,1 regarding the development of a new spontaneous intracerebral hemorrhage (sICH) grading scale, formally called ICH-GS, for the prediction of outcome after primary sICH. In comparison with other cerebrovascular diseases, there are no gradi...
متن کاملGlycemia in spontaneous intracerebral hemorrhage: clinical implications
Spontaneous cerebral hemorrhage or intracranial hemorrhage accounts for 10-15% of all strokes. Intracranial hemorrhage is much less common than ischemic stroke, but has higher mortality and morbidity, one of the leading causes of severe disability. Various alterations, among these the endocrine were identified when an intracerebral hemorrhage, these stress-mediated mechanisms exacerbate seconda...
متن کاملSpecial Feature Ongoing Clinical Trials in AKI
AKI is an important public health issue. AKI is a common hospital complication associated with increased inhospital and long-term mortality, extensive morbidity (including prolonged hospital length of stay), and an estimated annual cost of at least $10 billion in the United States. At present, no specific therapy has been developed to prevent AKI, hasten recovery of kidney function, or abrogate...
متن کاملProtecting patients in ongoing clinical trials.
In the fall of 2008, retiree John Dennis sued Anapharm, one of Canada’s largest clinical research firms, alleging he’d been injured after participating in a clinical trial three years earlier. Dennis, of Drummondville, Quebec, ingested a trial drug as part of a study in the fall of 2005 and was rushed from the testing facility to the emergency room at McGill University Health Centre in Montréal...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Stroke
سال: 2013
ISSN: 0039-2499,1524-4628
DOI: 10.1161/strokeaha.111.000563